Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies

Natalia Shirokova1, Ernst Niggli

  • 1Department of Pharmacology and Physiology, University of Medicine and Dentistry - NJMS, Newark, NJ 07103, USA. nshiroko@umdnj.edu

Insights

Duchenne Muscular Dystrophy causes heart failure due to a lack of dystrophin, leading to cardiac muscle fibrosis and cardiomyocyte dysfunction. This review summarizes cellular mechanisms behind this inevitable complication.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Cellular Biology

Background:

  • Duchenne Muscular Dystrophy (DMD) is a fatal genetic disorder characterized by progressive skeletal muscle degeneration.
  • A significant and often fatal complication of DMD is dilated cardiomyopathy, affecting cardiac muscle.
  • The underlying cause is the absence of functional dystrophin, a protein crucial for muscle cell structural integrity.

Purpose of the Study:

  • To summarize current findings on the cellular mechanisms driving cardiac dysfunction in DMD.
  • To provide an overview of the progression of dilated cardiomyopathy in DMD patients.
  • To highlight key research areas in understanding and potentially treating DMD-associated heart disease.

Main Methods:

  • Review of existing laboratory findings and published research.
  • Focus on cellular and molecular mechanisms of cardiac pathology in DMD.
  • Synthesis of data from multiple research groups studying dystrophy.

Main Results:

  • Lack of dystrophin leads to cytoskeletal instability in cardiomyocytes.
  • Cardiac muscle fibrosis and impaired cardiomyocyte function are key pathological features.
  • These cellular changes culminate in congestive heart failure and arrhythmias.

Conclusions:

  • Dilated cardiomyopathy is an unavoidable consequence of DMD due to dystrophin deficiency.
  • Understanding cellular mechanisms is critical for developing therapeutic strategies.
  • Further research into cardiac protection in DMD is warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...